About us
Dedicated to healthcare professionals, Microbiota Events aims to build a global community in which members gain access to the latest research, developments and up-to-date scientific content in the microbiota field.
Improvements in human health.
Using the latest technologies and with new programming continuously added throughout the year, Microbiota Events is a unique digital source of consolidated knowledge, information and data from international experts.
Biocodex is a French family-owned pharmaceutical company. The company was founded in 1953 to develop and market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745, discovered in 1923. Since then, Biocodex has evolved from a pioneer to a major international player in the microbiota realm.
Its "Microbiota Mission" is to educate both general public and healthcare professionals on the growing importance of microbiota, advance scientific breakthroughs in microbiota by funding academic research, provide solutions for preserving microbiota health with its unique probiotic drug S. boulardii CNCM I-745, innovate with its Symbiosys range and make early-stage investments in start-up companies.
